Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EPI-VT: Ablation Strategies for Ventricular Tachycardia in Ischemic Cardiomyopathy
NCT04512911Phase 1Withdrawn
- Sponsor
- Montefiore Medical Center
- Start
- Jan 2023
- Primary completion
- Jan 2023
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial (5 arms), sponsored by Montefiore Medical Center. Primary endpoints: Freedom from documented VT episodes at 12 months and Freedom from documented VT episodes after second intervention at 12 months. Planned start Jan 2023; status: withdrawn.
Beyond the preview
Go deeper on NCT04512911.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04512911.